Amanote Research

Amanote Research

    RegisterSign In

Why Isn't the NHS Making the Most of Biosimilar Insulin?

Prescriber - United Kingdom
doi 10.1002/psb.1781
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

August 1, 2019

Authors
Mark Greener
Publisher

Wiley


Related search

Shared Decision Making: Everyone Wants It, So Why Isn't It Happening?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2017English

Why Isn'T Sociology a Science?

Perception
OphthalmologySensory SystemsExperimentalArtificial IntelligenceCognitive Psychology
1995English

FDA-Approved Biosimilar Insulin

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2014English

Why Isn't Everyone a Bayesian?

American Statistician
MathematicsStatisticsUncertaintyProbability
1986English

Making the Most of the Olympics

British Medical Journal
Medicine
2012English

Making the Most of Retirement

Pensions: An International Journal
2012English

Making the Most of the Host

Science-Business eXchange
2011English

Interpreters: Why Should the NHS Provide Them?

British Journal of General Practice
MedicineFamily Practice
2018English

Making the Most of High Inflation

Applied Economics
EconomicsEconometrics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy